Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123480582 | 12348058 | 2 | F | 20160131 | 20160718 | 20160509 | 20160801 | EXP | FR-GE HEALTHCARE MEDICAL DIAGNOSTICS-VISP-PR-1605S-0253 | GE HEALTHCARE | 54.61 | YR | M | Y | 0.00000 | 20160801 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123480582 | 12348058 | 1 | PS | VISIPAQUE | IODIXANOL | 1 | Intravenous (not otherwise specified) | DOSE NOT REPORTED | 20351 | SOLUTION FOR INJECTION | |||||||||
| 123480582 | 12348058 | 2 | SS | VISIPAQUE | IODIXANOL | 1 | 20351 | ||||||||||||
| 123480582 | 12348058 | 3 | SS | VOLUVEN | HYDROXYETHYL STARCH 130/0.4 | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 123480582 | 12348058 | 4 | SS | ARIXTRA | FONDAPARINUX SODIUM | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 123480582 | 12348058 | 5 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 0 | 75 | MG | |||||||||
| 123480582 | 12348058 | 6 | C | TICAGRELOR | TICAGRELOR | 1 | Oral | 0 | 90 | MG | |||||||||
| 123480582 | 12348058 | 7 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 80 | MG | |||||||||
| 123480582 | 12348058 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | |||||||||
| 123480582 | 12348058 | 9 | C | BOSOCE | 2 | Oral | 0 | 5 | MG | ||||||||||
| 123480582 | 12348058 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | 2.5 | MG | ||||||||||
| 123480582 | 12348058 | 11 | C | HEPARIN | HEPARIN SODIUM | 1 | Unknown | DOSE NOT REPORTED | 0 | ||||||||||
| 123480582 | 12348058 | 12 | C | TILDIEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123480582 | 12348058 | 13 | C | ISOSORBIDE DINITRATE. | ISOSORBIDE DINITRATE | 1 | 0 | ||||||||||||
| 123480582 | 12348058 | 14 | C | ATROPINE. | ATROPINE | 1 | 0 | ||||||||||||
| 123480582 | 12348058 | 15 | C | TIROFIBAN HYDROCHLORIDE. | TIROFIBAN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123480582 | 12348058 | 1 | Chest pain |
| 123480582 | 12348058 | 2 | Diagnostic procedure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123480582 | 12348058 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123480582 | 12348058 | Erythema | |
| 123480582 | 12348058 | Erythema multiforme | |
| 123480582 | 12348058 | Pruritus | |
| 123480582 | 12348058 | Toxic skin eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123480582 | 12348058 | 1 | 20160126 | 20160126 | 0 | |
| 123480582 | 12348058 | 3 | 20160126 | 0 | ||
| 123480582 | 12348058 | 4 | 20160126 | 0 | ||
| 123480582 | 12348058 | 5 | 20160126 | 0 | ||
| 123480582 | 12348058 | 6 | 20160126 | 20160129 | 0 | |
| 123480582 | 12348058 | 7 | 20160126 | 0 | ||
| 123480582 | 12348058 | 8 | 20160128 | 0 | ||
| 123480582 | 12348058 | 9 | 20160128 | 0 | ||
| 123480582 | 12348058 | 10 | 20160129 | 0 | ||
| 123480582 | 12348058 | 11 | 20160126 | 0 |